Table 1 Demographics of focus group discussion and in-depth interview participants (N = 28)
|  | HIV-positive individuals on ART | HIV-negative individuals on PrEP (n = 4) | Providers (n = 8) | |
|---|---|---|---|---|
Viral load < 200 copies/mL (n = 10)* | Viral load ≥ 200 copies/mL (n = 6)** | |||
Gender | ||||
 Male | 6 | 5 | 4 | 4 |
 Female | 3 | 1 | 0 | 4 |
 Transgender female | 1 | 0 | 0 | 0 |
Age, median (range) | 57 (39–65) | 48 (32–57) | 35 (31–55) | 49 (38–65) |
Race | ||||
 American Indian/Alaskan Native | 2 | 0 | 0 | 0 |
 Asian | 1 | 0 | 0 | 3 |
 Black/African American | 4 | 3 | 0 | 0 |
 Native Hawaiian/Pacific Islander | 0 | 1 | 0 | 0 |
 White | 3 | 2 | 3 | 5 |
 Other | 0 | 0 | 1 | 0 |
Latino/Hispanic/Chicano | 0 | 0 | 2 | 0 |
Highest Level of Education | ||||
 Some secondary education/high school (9–12 years) | 2 | 0 | 0 | 0 |
 High school graduate or GED | 3 | 5 | 1 | 0 |
 College or associates degree | 4 | 1 | 2 | 0 |
 Advanced degree | 0 | 0 | 1 | 8 |
Years on HIV medications | ||||
  < 1 year | 0 | 1 | 1 | – |
 1–5 years | 1 | 1 | 3 | – |
  > 5–10 years | 2 | 0 | 0 | – |
 > 10 years | 7 | 4 | 0 | – |
Years providing care for ART/PrEP | ||||
 < 5 years | – | – | – | 1 |
 5–20 years | – | – | – | 3 |
 > 20 years | – | – | – | 4 |